Literature DB >> 25774666

Unraveling the Link Between Ectodermal Disorders and Primary Immunodeficiencies.

Roberta D'Assante1, Anna Fusco1, Loredana Palamaro1, Giuliana Giardino1, Vera Gallo1, Emilia Cirillo1, Claudio Pignata1.   

Abstract

Primary immunodeficiencies (PIDs) include a heterogeneous group of mostly monogenic diseases characterized by functional/developmental alterations of the immune system. Skin and skin annexa abnormalities may be a warning sign of immunodeficiency, since both epidermal and thymic epithelium have ectodermal origin. In this review, we will focus on the most common immune disorders associated with ectodermal alterations. Elevated IgE levels represent the immunological hallmark of hyper-IgE syndrome, characterized by severe eczema and susceptibility to infections. Ectodermal dysplasia (ED) is a group of rare disorders that affect tissues of ectodermal origin. Hypoidrotic ED (HED), the most common form, is inherited as autosomal dominant, autosomal recessive or X-linked trait (XLHED). HED and XLHED are caused by mutations in NEMO and EDA-1 genes, respectively, and show similarities in the cutaneous involvement but differences in the susceptibility to infections and immunological phenotype. Alterations in the transcription factor FOXN1 gene, expressed in the mature thymic and skin epithelia, are responsible for human and murine athymia and prevent the development of the T-cell compartment associated to ectodermal abnormalities such as alopecia and nail dystrophy. The association between developmental abnormalities of the skin and immunodeficiencies suggest a role of the skin as a primary lymphoid organ. Recently, it has been demonstrated that a co-culture of human skin-derived keratinocytes and fibroblasts, in the absence of thymic components, can support the survival of human haematopoietic stem cells and their differentiation into T-lineage committed cells.

Entities:  

Keywords:  FOXN1; T-cell development; ectodermal dysplasia; hyper-IgE; primary immunodeficiencies

Mesh:

Year:  2015        PMID: 25774666     DOI: 10.3109/08830185.2015.1010724

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  5 in total

1.  Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.

Authors:  Marita Bosticardo; Yasuhiro Yamazaki; Jennifer Cowan; Giuliana Giardino; Cristina Corsino; Giulia Scalia; Rosaria Prencipe; Melanie Ruffner; David A Hill; Inga Sakovich; Irma Yemialyanava; Jonathan S Tam; Nurcicek Padem; Melissa E Elder; John W Sleasman; Elena Perez; Hana Niebur; Christine M Seroogy; Svetlana Sharapova; Jennifer Gebbia; Gary Ira Kleiner; Jane Peake; Jordan K Abbott; Erwin W Gelfand; Elena Crestani; Catherine Biggs; Manish J Butte; Nicholas Hartog; Anthony Hayward; Karin Chen; Jennifer Heimall; Filiz Seeborg; Lisa M Bartnikas; Megan A Cooper; Claudio Pignata; Avinash Bhandoola; Luigi D Notarangelo
Journal:  Am J Hum Genet       Date:  2019-08-22       Impact factor: 11.025

Review 2.  FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches.

Authors:  Vera Gallo; Emilia Cirillo; Giuliana Giardino; Claudio Pignata
Journal:  J Clin Immunol       Date:  2017-09-21       Impact factor: 8.317

Review 3.  SCID newborn screening: What we've learned.

Authors:  Robert Currier; Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2021-02       Impact factor: 14.290

4.  Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib.

Authors:  Xiangqian Li; Xia Wu; Dirk M Elston; Jianzhong Zhang; Cheng Zhou
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

Review 5.  FOXN1 deficient nude severe combined immunodeficiency.

Authors:  Ioanna A Rota; Fatima Dhalla
Journal:  Orphanet J Rare Dis       Date:  2017-01-11       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.